INS and type 2 diabetes mellitus: That GPER also functions to enhance insulin secretion in humans has been demonstrated in pancreatic islets isolated from type 2 diabetic patients where glucose-stimulated insulin secretion increased, while glucagon and somatostatin secretion decreased, upon G-1 stimulation (185, 186).